Select Bibliography

Filter by any of these (after searching):

NCCTG-N9942

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 1 items

Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.

Haddock, Michael G , Swaminathan, Revathi , Foster, Nathan R ... - - J Clin Oncol - 2007

Manuscript - Primary - Primary - GI - NCCTG-N9942